| 2009 |
PTCD3 is a mitochondrial protein that associates with the small subunit of mitochondrial ribosomes. Knockdown of PTCD3 in 143B osteosarcoma cells decreased mitochondrial protein synthesis, mitochondrial respiration, and the activity of Complexes III and IV, without affecting mitochondrial mRNA levels, indicating PTCD3 has a role in mitochondrial translation but not RNA processing/stability. |
Subcellular fractionation, mitoribosome subunit association assay, siRNA knockdown with mitochondrial protein synthesis assay, respirometry, and complex activity assays |
FEBS letters |
High |
19427859
|
| 2011 |
PTCD3 co-purifies with the mitochondrial transcription elongation factor TEFM complex, which also contains mitochondrial RNA polymerase (POLRMT), mitochondrial transcripts, and DHX30; after RNase treatment only POLRMT remained associated with TEFM, indicating PTCD3's association with TEFM is RNA-mediated. |
Affinity purification of TEFM from human mitochondria followed by mass spectrometry; RNase treatment dissociation experiment |
Nucleic acids research |
Medium |
21278163
|
| 2011 |
PTCD3 (Pet309 ortholog) cross-links to mitochondrial translation initiation factor IF3mt, placing it near the IF3mt binding site on the mitochondrial small ribosomal subunit. This cross-linking was confirmed by mass spectrometry and establishes PTCD3 as a small subunit ribosomal protein positioned at the IF3mt interface. |
Chemical cross-linking of IF3mt to mitoribosome small subunit followed by mass spectrometry identification; truncation mutant controls |
Biochimica et biophysica acta |
Medium |
22015679
|
| 2013 |
PTCD3 was formally identified as MRPS39, a component of the mitochondrial ribosome small subunit. siRNA knockdown confirmed an essential role in mitochondrial protein synthesis, as demonstrated by significant effects on mitochondrially encoded protein expression. |
Mass spectrometry-based identification of mitoribosome components; siRNA knockdown with immunoblot analysis of mitochondrially encoded proteins |
Frontiers in physiology |
Medium |
23908630
|
| 2016 |
Ptcd3 is required for tumor maintenance in Myc-driven mouse B-cell lymphomas, as identified through an in vivo reverse-genetic screen targeting Myc-activated mRNAs; inhibition of mitochondrial translation was synthetic-lethal with Myc activation. |
In vivo reverse-genetic RNAi screen in mouse B-cell lymphoma model; mitochondrial translation inhibition with tigecycline in vitro and in vivo |
Oncotarget |
Medium |
27635472
|
| 2019 |
Biallelic loss-of-function variants in PTCD3 cause combined oxidative phosphorylation deficiency (reduced Complex I and IV levels and activities, decreased oxygen consumption and ATP biosynthesis) and generalized mitochondrial translation defects in patient fibroblasts. Complementation with wild-type PTCD3 rescued these defects, functionally validating pathogenicity. Quantitative proteomics showed decreased levels of small mitoribosomal subunits. |
Exome sequencing, patient fibroblast biochemical assays (complex activity, oxygen consumption, ATP biosynthesis), quantitative proteomics of mitoribosome subunits, complementation experiments with wild-type PTCD3 |
Neurogenetics |
High |
30607703
|
| 2020 |
PTCD3 (mS39) forms a dedicated mRNA entry platform on the mitochondrial small ribosomal subunit. Cryo-EM structure (~3.0 Å) of the human mitoribosome revealed that mS39 is the contact site through which the LRPPRC-SLIRP complex delivers mt-mRNA to the ribosome for translation. |
Cryo-electron microscopy structural determination of human mitoribosome functional complexes at ~3.0 Å resolution |
eLife |
High |
32812867
|
| 2022 |
PTCD3 deficiency caused by compound heterozygous variants leads to severely reduced PTCD3 protein levels in patient fibroblasts, reduction in steady-state levels of complexes I and IV subunits and their activities, and decreased mitochondrial respiratory capacity. Functional complementation with wild-type PTCD3 restored complex levels and respiratory capacity, confirming PTCD3's essential role in mitochondrial translation. |
Patient fibroblast biochemical characterization (western blot, complex activity, high-resolution respirometry), minigene splicing assays, complementation experiments |
Brain pathology (Zurich, Switzerland) |
High |
36450274
|
| 2024 |
PTCD3/mS39 directly associates with LRPPRC through recognition of LRPPRC helical repeats, together with the N-terminus of mS31, forming a corridor for handoff of mRNA to the mitoribosome. Cryo-EM structure of LRPPRC-SLIRP-mRNA-mitoribosome complex at high resolution showed that mS39 is the primary mitoribosomal contact for LRPPRC-mediated mRNA delivery. |
Cryo-electron microscopy structure of LRPPRC-SLIRP-mRNA-mitoribosome complex; RNA sequencing, metabolic labeling, and mitoribosome profiling for functional validation |
Nature structural & molecular biology |
High |
39134711
|
| 2024 |
PTCD3/MRPS39 forms the entry channel of the mitochondrial small ribosomal subunit and binds to single-stranded mRNA. Pathogenic variants including a nonsense variant (p.Tyr394Ter) that ablates the C-terminal half (including the central fold) and a missense variant (p.His269Tyr) cause combined oxidative phosphorylation deficiency with decreased basal respiration rate. |
Whole genome sequencing, RT-PCR splicing assay, in silico structural modelling of variants, respirometry of patient-derived cells |
JIMD reports |
Medium |
39544688
|
| 2023 |
The Drosophila melanogaster ortholog of PTCD3 (encoded by CG4679) is essential for development; loss-of-function mutants are lethal at the second instar larval stage, with reduced expression of mitochondrial function and ribosome biogenesis genes, confirming an in vivo requirement for PTCD3 in mitochondrial RNA metabolism and development. |
Loss-of-function genetic mutant analysis in Drosophila; transcriptomic profiling of mutant larvae |
microPublication biology |
Medium |
38074476
|
| 2025 |
PTCD3 promotes SLC38A2 mRNA stability in colorectal cancer cells in an IGF2BP2-dependent manner, enhancing glutaminolysis and cancer cell migration and invasion. KAT2A promotes PTCD3 expression by increasing H3K27 acetylation at the PTCD3 locus. PTCD3 knockdown suppressed CRC glutaminolysis, proliferation, and metastasis in vitro and in vivo. |
Co-IP, RIP (RNA immunoprecipitation), dual-luciferase assay for PTCD3-IGF2BP2-SLC38A2 interaction; ChIP for H3K27 acetylation; xenograft mouse model; CCK-8, scratch, Transwell assays |
FASEB journal |
Medium |
40304977
|